TrialDrugs & aging2025

Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study.

Francesco Bartoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.